Table 2 |.
ECM component and/or remodelling molecules | Source | Functions | Pathology and/or epileptogenic effects | Refs |
---|---|---|---|---|
CSPG and/or CS-GAGs | Neurons, astrocytes and radial glia |
|
|
110,118,133,136 |
HSPGs and/or glypicans | Astrocytes, neurons and endothelial cells | Synaptogenesis and synaptic maturation |
|
136–138 |
Tenascin C | Astrocytes, neurons, radial glial and epithelial cells |
|
|
12,103,139,140 |
Tenascin R | Neurons and oligodendrocytes |
|
|
12,103,140–142 |
HA | Neurons and astrocytes |
|
|
103,108,109,136 |
MMPs | Astrocytes, endothelial cells, neurons, microglia and oligodendrocytes |
|
|
12,105,106,143,144 |
ADAMTs | Neurons, astrocytes, microglia, monocytes and macrophages |
|
|
103,145–147 |
tPA | Neurons and microglia |
|
|
103,146,148 |
TSPs | Astrocytes and macrophages |
|
|
12,140 |
Reelin | Cajal-Retzius cells and interneurons |
|
|
103,149 |
Hevin | Vasculature cells, astrocytes, radial glia and neurons |
|
|
15,103,140 |
SPARC | Radial glia, vasculature cells, astrocytes and microglia |
|
|
140,150 |
ADAMTs, a disintegrin and metalloproteinase with thrombospondin motifs; CS–GAG, chondroitin sulfate–glycosaminoglycan; CSPG, chondroitin sulfate proteoglycan; DGC, dentate granule cell; ECM, extracellular matrix; HA, hyaluronic acid; HSPG, heparin sulfate proteoglycan; LTP, long-term potentiation; MMP, matrix metalloproteinase; PNN, perineuronal net; PV+, parvalbumin positive; SPARC, secreted protein acidic and rich in cysteine; TLE, temporal lobe epilepsy; tPA, tissue plasminogen activator; TSP, thrombospondin.